# Gamma Interferon Therapy for Chronic Hepatitis C

> **NCT00028275** · PHASE2 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 20 (—)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Gamma Interferon 1b

## Key facts

- **NCT ID:** NCT00028275
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** —
- **Final completion:** 2003-11
- **Target enrollment:** 20 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00028275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00028275, "Gamma Interferon Therapy for Chronic Hepatitis C". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00028275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*